Understanding the biology of tumors
When people hear “tumor” they typically, and immediately, associate the word with cancer. However, one of the most important points to remember is that a
Read More
Cancer
Targeting B-cell malignancies with κ-specific T cells can lead to complete clinical responses
Treating cancer with the patient’s own immune cells has been successful. In particular, treating B cell malignancies with the patients’ own immune T cells modified
Read More
Know your risk for developing head and neck cancer
You can never prepare yourself to hear the words, “you have cancer.” However, for some types of cancer, there are screenings you can get to
Read More
PaintFest America brings creativity, healing to cancer patients
For those dealing with a cancer diagnosis, painting can be a therapeutic way to cope with difficult circumstances, explore creativity and bond with friends and
Read More
Theatre monologues, art car help promote cancer awareness and nutrition education
Encouraging cancer awareness in a city as diverse as Houston requires a range of educational tools and cultural understanding. From its Theatre Outreach Program to
Read More
From Brazil to Baylor: Avon Global Breast Cancer Clinical Scholars
Beyond providing excellence in care to patients with breast cancer and developing new approaches to treating the disease, Baylor College of Medicine’s Lester and Sue
Read More
Throwback Thursday: Breaking ground
Did you know that the nation’s first nuclear protein laboratory was organized at Baylor College of Medicine? In this 1972 photo from Inside Baylor Medicine
Read More
The mTOR pathway: a new avenue for breast cancer cells to promote tumor growth
Cancer cells respond in various ways to the body’s attempts to eliminate them. One strategy is to recruit immune cells in the body, such as
Read More
Image of the Month: C60 fullerene ‘bucky balls’ help deliver pharmacologic agents to cancer cells
Drs. Steven Curley and Stuart Corr in the Electromagnetic Field and Nanomaterials Research Laboratory at Baylor are linking nanoparticles, such as the C60 fullerene bucky
Read More
New class of small molecule, SI-2, can drug the ‘undruggable’ steroid receptor coactivator-3
By Ana María Rodríguez, Ph.D. Steroid receptor coactivator-3, which is well-known for its role in cancer formation and proliferation, is usually considered ‘undruggable’ because this nuclear
Read More